Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists

Drugs formulated from monoclonal antibodies (mAbs) are clinically effective in various diseases. Repeated administration of mAbs, however, elicits an immune response in the form of anti-drug-antibodies (ADA), thereby reducing the drug's efficacy. Notwithstanding their importance, the molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaisman-Mentesh, Anna, Rosenstein, Shai, Yavzori, Miri, Dror, Yael, Fudim, Ella, Ungar, Bella, Kopylov, Uri, Picard, Orit, Kigel, Aya, Ben-Horin, Shomron, Benhar, Itai, Wine, Yariv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930160/
https://www.ncbi.nlm.nih.gov/pubmed/31921180
http://dx.doi.org/10.3389/fimmu.2019.02921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930160/
https://www.ncbi.nlm.nih.gov/pubmed/31921180
http://dx.doi.org/10.3389/fimmu.2019.02921

Ejemplares similares